News

TriSalus Life Sciences® Inc., an oncology company specializing in novel delivery technologies combined with immunotherapy for liver and pancreatic...

Volastra Therapeutics, a clinical-stage biotechnology company at the forefront of developing cancer treatments targeting chromosomal instability (CIN), has announced...

Bristol Myers Squibb (BMY) has launched a $1.8 million initiative to advance health equity by addressing the social determinants...

Arrowhead Pharmaceuticals, Inc. has launched an Expanded Access Program (EAP) to offer plozasiran, its investigational therapy, to patients with...

Actylis and Novo Nordisk Pharmatech A/S have partnered to distribute pharmaceutical-grade Benzalkonium Chloride (BKC) in key European markets, including...

Verge Genomics and Ferrer have embarked on a strategic partnership to advance the development and potential commercialization of VRG50635,...

Gilead Sciences, Inc. has finalized its acquisition of CymaBay Therapeutics, Inc. for an approximate total equity value of $4.3...

Esperion has announced a pivotal development in cardiovascular treatment, with the FDA approving broad label expansions for NEXLETOL® (bempedoic...

LIB Therapeutics, Inc. (LIB), a pioneering biopharmaceutical company, has made considerable progress with its cholesterol-lowering drug, Lerodalcibep and designed...

The “Global Digital Biomarkers Market – Outlook & Forecast 2024-2029” report showcases the rapidly expanding digital biomarkers market, which...